{
    "MET Exon 14 Skipping Mutation Positive": {
        "First-line Therapy": {
            "Capmatinib": "Progression (See NSCL-26)",
            "Tepotinib": "Progression (See NSCL-26)",
            "Crizotinib": "Progression (See NSCL-26)"
        },
        "Progression": {
            "Immunotherapy +/- Chemotherapy": "Progression (See NSCL-26)"
        }
    },
    "footnotes": {
        "1": "See Principles of Systemic Therapy (NSCL-F)."
    }
}